Name
Aktsiaselts Medical Pharmacy Group
Registry code
12356191
VAT number
EE101743570
Type
AS - Joint Stock Company
Status
Bankrupt
Foundation date
04.10.2012 (12)
Financial year
01.01-31.12
Capital
518 986.00 €
Activity
47911 - Retail sale via mail order houses or via Internet 9609 - Other personal service activities n.e.c. 21201 - Manufacture of pharmaceutical preparations
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pre.IPO.Capital AS 14770693 | 73% - 377 859.40 EUR | - | - | Shareholder |
| Jüri Truuts
| - | Bankruptcy trustee | - | |
| Rein Muoni
| - | - | - | Board member |
| Tarmo Oras
| - | - | - | Board member |
| Toomas Kaevand
| - | - | - | Board member |
| Swen Uusjärv
| - | - | - | Chairman of the board |
| Worldlife Estonia OÜ 12178803 | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MTÜ Personalised Medicine Association 80561497 | - | - | - | Founder (without contribution) |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | - | - | - | 1 |
| 2024 Q3 | - | - | - | 1 |
| 2024 Q2 | - | - | - | 1 |
| 2024 Q1 | - | 9 050.07 € | 4 577.07 € | 8 |
| 2023 Q4 | 34 921.66 € | 7 255.53 € | 6 713.75 € | 7 |
| 2023 Q3 | 40 115.64 € | 24 598.04 € | 17 478.72 € | 7 |
| 2023 Q2 | 40 547.98 € | 805.75 € | 607.44 € | 7 |
| 2023 Q1 | 46 373.22 € | 17 326.59 € | 10 247.84 € | 9 |
| 2022 Q4 | 66 174.16 € | 34 189.83 € | 27 382.35 € | 10 |
| 2022 Q3 | 40 182.58 € | - | - | 9 |
| 2022 Q2 | - | - | - | 8 |
| 2022 Q1 | - | 10 714.73 € | 7 723.83 € | 8 |
| 2021 Q4 | 20 007.72 € | 22 686.06 € | 14 381.14 € | 8 |
| 2021 Q3 | 55 101.65 € | 48 032.84 € | 38 207.19 € | 9 |
| 2021 Q2 | 104 521.89 € | 19 228.09 € | 19 650.07 € | 13 |
| 2021 Q1 | 81 826.75 € | 11 601.5 € | 9 318.36 € | 15 |
| 2020 Q4 | 148 264.98 € | 37 430.33 € | 34 142.12 € | 13 |
| 2020 Q3 | 105 039.66 € | 4 485 € | 5 010.42 € | 14 |
| 2020 Q2 | 131 998.89 € | 9 477.3 € | 9 477.3 € | 18 |
| 2020 Q1 | 108 380.99 € | 45 228.28 € | 49 543.34 € | 28 |
